{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# LMNA FPLD2\n",
    "[Familial partial lipodystrophy type 2 (FPLD2)](https://omim.org/entry/151660) is caused by heterozygous mutation in the gene encoding lamin A/C (LMNA).\n",
    "\n",
    "- Data taken from  [Lanktree M, et al. (2007) Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660). Clin Genet ;71(2):183-6. PMID:17250669](https://pubmed.ncbi.nlm.nih.gov/17250669/).\n",
    "\n",
    "The authors write:\n",
    "The clinical and biochemical attributes of the three patients are shown in Table 1. Each had typical loss of subcutaneous adipose in the limbs and gluteal region, although these findings were less pronounced for patient C, as often is the case with men. Each had insulin resistance and type 2 diabetes mellitus although none had acanthosis nigricans. Each had high triglycerides and depressed high-density lipoprotein cholesterol. No findings of other laminopathies were present in any patient.\n",
    "\n",
    "The authors write that No findings of other laminopathies were present in any patient.\n",
    "Therefore, we exclude several characteristic findings\n",
    "\n",
    "- Proptosis (HP:0000520); \n",
    "- Failure to thrive (HP:0001508); \n",
    "- Micrognathia (HP:0000347); \n",
    "- Alopecia (HP:0001596); \n",
    "- Short stature (HP:0004322); \n",
    "- Scleroderma (HP:0100324); \n",
    "- Prominent superficial blood vessels (HP:0007394); \n",
    "- Mottled pigmentation (HP:0001070)\n",
    "- Progeroid facial appearance HP:0005328\n",
    "- Cardiomyopathy (HP:0001638)\n",
    "- Atrioventricular block (HP:0001678)\n",
    "- Muscle weakness (HP:0001324)\n",
    "\n",
    "\n",
    "\n",
    "- Data extracted from [Schmidt HH, et al. (2001) Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metab. 86(5):2289-95.  PMID:11344241](https://pubmed.ncbi.nlm.nih.gov/11344241/)\n",
    "\n",
    "The authors write:\n",
    "The affected adult patients of this family characteristically present in the sequence of appearance with loss of sc fat of the extremities, muscular hypertrophy especially of the lower legs, acanthosis nigricans, severe hypertriglyceridemia, and insulin-resistant diabetes mellitus. Remarkably, affected members of this family present with severe myalgia, especially after exercise.\n",
    "See also the clinical vignette.\n",
    "\n",
    "Here, we created phenopackets for the three adults members of the family for whome detailed clinical information is available.\n",
    "\n",
    "Additional data was curated from [Besci O, et al. Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review. J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1204-e1224](https://pubmed.ncbi.nlm.nih.gov/37843397/). For curation, the following assumptions were made\n",
    "\n",
    "- LDL cholesterol: curated as elevated for 130 mg/dL and above\n",
    "- HBA1c: curated as elevated for  5.7% and above\n",
    "- HDL cholesteral: reduced if 40 mg/dl or below\n",
    "- trigylcerides: elevated if High: 200 mg/dL or above\n",
    "- total cholesteral: elevated if 200 mg/dl or above\n",
    "\n",
    "The patients carrying the R644C variant demonstrated an atypical FPLD2 phenotype (patients Patient 1.1-1.7), while the rest of the patients demonstrated the classic FPLD2 phenotype.\n",
    "Ninety-eight percent (n = 89) of patients presented with FPLD2 phenotypes, while one had generalized lipodystrophy without progeroid features (n = 1, T10I). \n",
    "Typical FPLD2 was defined by loss of adipose tissue from the upper and lower extremities and trunk, with an excess of adipose tissue in the face, neck, and supraclavicular region. \n",
    "\n",
    "Atypical FPLD2 was defined when adipose tissue loss was less severe, with lipoatrophy being more evident in the legs. \n",
    "\n",
    "Coded as \n",
    "- Lipodystrophy (HP:0009125)\n",
    "- Loss of subcutaneous adipose tissue in limbs HP:0003635\n",
    "- Loss of truncal subcutaneous adipose tissue HP:0009002 (not atypical)\n",
    "- Generalized lipodystrophy HP:0009064 (Patient with T110I)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Using pyphetools version 0.9.113\n"
     ]
    }
   ],
   "source": [
    "from pyphetools.creation import TemplateImporter, Moi\n",
    "from pyphetools.visualization import IndividualTable, QcVisualizer\n",
    "from IPython.display import display, HTML\n",
    "import pyphetools\n",
    "print(f\"Using pyphetools version {pyphetools.__version__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HPO version 2024-08-13\n",
      "Created encoders for 88 fields\n",
      "Importing OMIM:151660, Lipodystrophy, familial partial, type 2, HGNC:6636, LMNA,  NM_170707.4\n",
      "We output 127 GA4GH phenopackets to the directory phenopackets\n"
     ]
    }
   ],
   "source": [
    "template = \"input/LMNA_FPLD2_individuals.xlsx\"\n",
    "created_by = \"0000-0002-0736-9199\"\n",
    "timporter = TemplateImporter(template=template, created_by=created_by)\n",
    "individual_list, cvalidator = timporter.import_phenopackets_from_template()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<h2>Cohort validation</h2>\n",
       "<p>Errors found with 12 of 127 phenopackets.</p>\n",
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>Error counts</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Level</th><th style=\"text-align: left;font-weight: bold;\">Error category</th><th style=\"text-align: left;font-weight: bold;\">Count</th></tr>\n",
       "<tr><td style=\"text-align: left;\">WARNING</td><td style=\"text-align: left;\">REDUNDANT</td><td style=\"text-align: left;\">16</td></tr>\n",
       "</table>\n",
       "<p>A total of 16 issues were fixed and no individual was removed from the cohort.</p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "qc = QcVisualizer(cohort_validator=cvalidator)\n",
    "display(HTML(qc.to_summary_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>127 phenopackets - PMID:17250669 (n=3); PMID:11344241 (n=3); PMID:37303127 (n=6); PMID:37843397 (n=115)</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Individual</th><th style=\"text-align: left;font-weight: bold;\">Disease</th><th style=\"text-align: left;font-weight: bold;\">Genotype</th><th style=\"text-align: left;font-weight: bold;\">Phenotypic features</th></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient A (FEMALE; P46Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.688G>A (heterozygous)</td><td style=\"text-align: left;\">Hyperglycemia (HP:0003074): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Type II diabetes mellitus (HP:0005978): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased facial adipose tissue (HP:0000287): onset ; Obesity (HP:0001513): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Acanthosis nigricans (HP:0000956): onset ; excluded: Proptosis (HP:0000520): onset ; excluded: Failure to thrive (HP:0001508): onset ; excluded: Micrognathia (HP:0000347): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Short stature (HP:0004322): onset ; excluded: Scleroderma (HP:0100324): onset ; excluded: Prominent superficial blood vessels (HP:0007394): onset ; excluded: Mottled pigmentation (HP:0001070): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Cardiomyopathy (HP:0001638): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Muscle weakness (HP:0001324): onset <br/><b>TimeElement(element=Age(iso8601duration=P44Y))</b>: Insulin-resistant diabetes mellitus (HP:0000831): onset age {\n",
       "  iso8601duration: \"P44Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient B (FEMALE; P50Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1195C>T (heterozygous)</td><td style=\"text-align: left;\">Hyperglycemia (HP:0003074): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Type II diabetes mellitus (HP:0005978): onset ; Skeletal muscle hypertrophy (HP:0003712): onset ; Hypertriglyceridemia (HP:0002155): onset ; Myopathy (HP:0003198): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Pancreatitis (HP:0001733): onset ; Xanthomatosis (HP:0000991): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Prominent superficial veins (HP:0001015): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Proptosis (HP:0000520): onset ; excluded: Failure to thrive (HP:0001508): onset ; excluded: Micrognathia (HP:0000347): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Short stature (HP:0004322): onset ; excluded: Scleroderma (HP:0100324): onset ; excluded: Mottled pigmentation (HP:0001070): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Cardiomyopathy (HP:0001638): onset ; excluded: Atrioventricular block (HP:0001678): onset <br/><b>TimeElement(element=Age(iso8601duration=P48Y))</b>: Insulin-resistant diabetes mellitus (HP:0000831): onset age {\n",
       "  iso8601duration: \"P48Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient C (MALE; P75Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1718C>T (heterozygous)</td><td style=\"text-align: left;\">Hyperglycemia (HP:0003074): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Type II diabetes mellitus (HP:0005978): onset ; Skeletal muscle hypertrophy (HP:0003712): onset ; Hypertriglyceridemia (HP:0002155): onset ; Myopathy (HP:0003198): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Pancreatitis (HP:0001733): onset ; Xanthomatosis (HP:0000991): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Prominent superficial veins (HP:0001015): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Proptosis (HP:0000520): onset ; excluded: Failure to thrive (HP:0001508): onset ; excluded: Micrognathia (HP:0000347): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Short stature (HP:0004322): onset ; excluded: Scleroderma (HP:0100324): onset ; excluded: Mottled pigmentation (HP:0001070): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Cardiomyopathy (HP:0001638): onset ; excluded: Atrioventricular block (HP:0001678): onset <br/><b>TimeElement(element=Age(iso8601duration=P57Y))</b>: Insulin-resistant diabetes mellitus (HP:0000831): onset age {\n",
       "  iso8601duration: \"P57Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual II-2 (FEMALE; P49Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Type II diabetes mellitus (HP:0005978): onset ; Skeletal muscle hypertrophy (HP:0003712): onset ; Hypertriglyceridemia (HP:0002155): onset ; Myopathy (HP:0003198): onset ; Exercise-induced myalgia (HP:0003738): onset ; Acanthosis nigricans (HP:0000956): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Muscle weakness (HP:0001324): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual III-2 (FEMALE; P36Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Generalized lipodystrophy (HP:0009064): onset ; Type II diabetes mellitus (HP:0005978): onset ; Skeletal muscle hypertrophy (HP:0003712): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatomegaly (HP:0002240): onset ; Splenomegaly (HP:0001744): onset ; Myopathy (HP:0003198): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Exercise-induced myalgia (HP:0003738): onset ; Acanthosis nigricans (HP:0000956): onset ; Obesity (HP:0001513): onset ; Xanthomatosis (HP:0000991): onset ; Constrictive median neuropathy (HP:0012185): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Abnormal circulating lipoprotein lipase concentration (HP:0033477): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual III-3 (MALE; P33Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Generalized lipodystrophy (HP:0009064): onset ; Type II diabetes mellitus (HP:0005978): onset ; Skeletal muscle hypertrophy (HP:0003712): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatomegaly (HP:0002240): onset ; Splenomegaly (HP:0001744): onset ; Myopathy (HP:0003198): onset ; Exercise-induced myalgia (HP:0003738): onset ; Acanthosis nigricans (HP:0000956): onset ; Obesity (HP:0001513): onset ; Xanthomatosis (HP:0000991): onset ; Constrictive median neuropathy (HP:0012185): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Muscle weakness (HP:0001324): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual 1 (MALE; P16Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.29C>T (heterozygous)</td><td style=\"text-align: left;\">Hyperinsulinemia (HP:0000842): onset ; Insulin resistance (HP:0000855): onset ; Hyperglycemia (HP:0003074): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Generalized lipodystrophy (HP:0009064): onset ; Type II diabetes mellitus (HP:0005978): onset ; Hypertriglyceridemia (HP:0002155): onset ; Increased circulating free fatty acid level (HP:0030781): onset ; Elevated circulating C-reactive protein concentration (HP:0011227): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Progeroid facial appearance (HP:0005328): onset ; Osteoporosis (HP:0000939): onset ; Elevated circulating alanine aminotransferase concentration (HP:0031964): onset ; Elevated circulating aspartate aminotransferase concentration (HP:0031956): onset ; Albuminuria (HP:0012592): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Short stature (HP:0004322): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Muscular dystrophy (HP:0003560): onset ; excluded: Scoliosis (HP:0002650): onset ; excluded: Achilles tendon contracture (HP:0001771): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Myotonia (HP:0002486): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Prolonged QT interval (HP:0001657): onset ; excluded: Abnormal circulating creatinine concentration (HP:0012100): onset ; excluded: Hyperuricemia (HP:0002149): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual 2 (FEMALE; P21Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.175C>G (heterozygous)</td><td style=\"text-align: left;\">Insulin resistance (HP:0000855): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Generalized lipodystrophy (HP:0009064): onset ; Glucose intolerance (HP:0001952): onset ; Elevated circulating C-reactive protein concentration (HP:0011227): onset ; Increased circulating NT-proBNP concentration (HP:0031185): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Short stature (HP:0004322): onset ; Progeroid facial appearance (HP:0005328): onset ; Cardiomyopathy (HP:0001638): onset ; Premature ovarian insufficiency (HP:0008209): onset ; Scoliosis (HP:0002650): onset ; Congestive heart failure (HP:0001635): onset ; Osteoporosis (HP:0000939): onset ; Hyperuricemia (HP:0002149): onset ; excluded: Hyperinsulinemia (HP:0000842): onset ; excluded: Hyperglycemia (HP:0003074): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased circulating free fatty acid level (HP:0030781): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Muscular dystrophy (HP:0003560): onset ; excluded: Achilles tendon contracture (HP:0001771): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Myotonia (HP:0002486): onset ; excluded: Prolonged QT interval (HP:0001657): onset ; excluded: Elevated circulating alanine aminotransferase concentration (HP:0031964): onset ; excluded: Elevated circulating aspartate aminotransferase concentration (HP:0031956): onset ; excluded: Abnormal circulating creatinine concentration (HP:0012100): onset ; excluded: Albuminuria (HP:0012592): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual 3 (FEMALE; P16Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Hyperinsulinemia (HP:0000842): onset ; Insulin resistance (HP:0000855): onset ; Hyperglycemia (HP:0003074): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Lipodystrophy (HP:0009125): onset ; Type II diabetes mellitus (HP:0005978): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Increased circulating free fatty acid level (HP:0030781): onset ; Elevated circulating C-reactive protein concentration (HP:0011227): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Elevated circulating alanine aminotransferase concentration (HP:0031964): onset ; Elevated circulating aspartate aminotransferase concentration (HP:0031956): onset ; Albuminuria (HP:0012592): onset ; excluded: Generalized lipodystrophy (HP:0009064): onset ; excluded: Increased circulating NT-proBNP concentration (HP:0031185): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Muscular dystrophy (HP:0003560): onset ; excluded: Scoliosis (HP:0002650): onset ; excluded: Achilles tendon contracture (HP:0001771): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Myotonia (HP:0002486): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Prolonged QT interval (HP:0001657): onset ; excluded: Osteoporosis (HP:0000939): onset ; excluded: Abnormal circulating creatinine concentration (HP:0012100): onset ; excluded: Hyperuricemia (HP:0002149): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual 4 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Hyperinsulinemia (HP:0000842): onset ; Insulin resistance (HP:0000855): onset ; Hyperglycemia (HP:0003074): onset ; Lipodystrophy (HP:0009125): onset ; Glucose intolerance (HP:0001952): onset ; Elevated circulating C-reactive protein concentration (HP:0011227): onset ; Prolonged QT interval (HP:0001657): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Generalized lipodystrophy (HP:0009064): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased circulating free fatty acid level (HP:0030781): onset ; excluded: Increased circulating NT-proBNP concentration (HP:0031185): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Muscular dystrophy (HP:0003560): onset ; excluded: Scoliosis (HP:0002650): onset ; excluded: Achilles tendon contracture (HP:0001771): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Myotonia (HP:0002486): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Osteoporosis (HP:0000939): onset ; excluded: Elevated circulating alanine aminotransferase concentration (HP:0031964): onset ; excluded: Elevated circulating aspartate aminotransferase concentration (HP:0031956): onset ; excluded: Abnormal circulating creatinine concentration (HP:0012100): onset ; excluded: Hyperuricemia (HP:0002149): onset ; excluded: Albuminuria (HP:0012592): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual 5 (MALE; P73Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Hyperinsulinemia (HP:0000842): onset ; Insulin resistance (HP:0000855): onset ; Hyperglycemia (HP:0003074): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Lipodystrophy (HP:0009125): onset ; Type II diabetes mellitus (HP:0005978): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Increased circulating free fatty acid level (HP:0030781): onset ; Increased circulating NT-proBNP concentration (HP:0031185): onset ; Hepatic steatosis (HP:0001397): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Hyperuricemia (HP:0002149): onset ; excluded: Generalized lipodystrophy (HP:0009064): onset ; excluded: Elevated circulating C-reactive protein concentration (HP:0011227): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Muscular dystrophy (HP:0003560): onset ; excluded: Scoliosis (HP:0002650): onset ; excluded: Achilles tendon contracture (HP:0001771): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Myotonia (HP:0002486): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Prolonged QT interval (HP:0001657): onset ; excluded: Osteoporosis (HP:0000939): onset ; excluded: Elevated circulating alanine aminotransferase concentration (HP:0031964): onset ; excluded: Elevated circulating aspartate aminotransferase concentration (HP:0031956): onset ; excluded: Abnormal circulating creatinine concentration (HP:0012100): onset ; excluded: Albuminuria (HP:0012592): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual 6 (FEMALE; P16Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Insulin resistance (HP:0000855): onset ; Hyperglycemia (HP:0003074): onset ; Elevated hemoglobin A1c (HP:0040217): onset ; Generalized lipodystrophy (HP:0009064): onset ; Type II diabetes mellitus (HP:0005978): onset ; Hypertriglyceridemia (HP:0002155): onset ; Increased circulating NT-proBNP concentration (HP:0031185): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Atrial fibrillation (HP:0005110): onset ; Muscular dystrophy (HP:0003560): onset ; Scoliosis (HP:0002650): onset ; Achilles tendon contracture (HP:0001771): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Myotonia (HP:0002486): onset ; Congestive heart failure (HP:0001635): onset ; Elevated circulating alanine aminotransferase concentration (HP:0031964): onset ; Elevated circulating aspartate aminotransferase concentration (HP:0031956): onset ; Hyperuricemia (HP:0002149): onset ; Albuminuria (HP:0012592): onset ; excluded: Hyperinsulinemia (HP:0000842): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased circulating free fatty acid level (HP:0030781): onset ; excluded: Elevated circulating C-reactive protein concentration (HP:0011227): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Prolonged QT interval (HP:0001657): onset ; excluded: Osteoporosis (HP:0000939): onset ; excluded: Abnormal circulating creatinine concentration (HP:0012100): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1.1 (FEMALE; P33Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1930C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P32Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P32Y\"\n",
       "}\n",
       "; Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P32Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1.2 (FEMALE; P44Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1930C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P44Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P44Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1.3 (FEMALE; P39Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1930C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P46Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P46Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1.4 (MALE; P32Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1930C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1.5 (MALE; P44Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1930C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P44Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P44Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1.6 (MALE; P45Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1930C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P45Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P45Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1.7 (MALE)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1930C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 2.1 (FEMALE; P52Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P56Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P56Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 2.2 (FEMALE; P14Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.1 (MALE; P49Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P32Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P32Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P35Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P35Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.2 (FEMALE; P23Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P23Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P23Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.3 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P47Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P47Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.4 (FEMALE; P45Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P46Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P46Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.5 (FEMALE; P5Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.6 (FEMALE; P42Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P43Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P43Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.7 (MALE; P28Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P28Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P28Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3.8 (FEMALE; P20Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 4.1 (FEMALE; P20Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P20Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P20Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 4.2 (FEMALE; P12Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P21Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P21Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 4.3 (FEMALE; P31Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 4.4 (FEMALE; P25Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 5.1 (FEMALE; P29Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P30Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P30Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P48Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P48Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 5.2 (FEMALE; P39Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P26Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P26Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 5.3 (FEMALE; P35Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Atrioventricular block (HP:0001678): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P36Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P36Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 6.1 (FEMALE; P46Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM1 (FEMALE; P41Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Obesity (HP:0001513): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM2 (FEMALE; P42Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Obesity (HP:0001513): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM3 (FEMALE; P33Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P33Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P33Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM4 (FEMALE; P47Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P47Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P47Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM5 (FEMALE; P62Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Obesity (HP:0001513): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P60Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P60Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM6 (FEMALE; P28Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P20Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P20Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM7 (FEMALE; P38Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P47Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P47Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM8 (MALE; P16Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Obesity (HP:0001513): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM9 (MALE; P15Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM10 (FEMALE; P20Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM11 (FEMALE; P18Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1488+5G>C (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Atrioventricular block (HP:0001678): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P18Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P18Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM12 (FEMALE; P20Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P19Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P19Y\"\n",
       "}\n",
       "; Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P19Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM13 (FEMALE; P55Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P20Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P20Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P45Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P45Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM14 (MALE; P44Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM15 (FEMALE; P23Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM16 (FEMALE; P63Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P64Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P64Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM17 (FEMALE; P47Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1745G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P47Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P47Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM18 (FEMALE; P55Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.184C>G (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P38Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P38Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P46Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P46Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM19 (MALE; P58Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P45Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P45Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM20 (FEMALE; P58Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P53Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P53Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM21 (MALE; P48Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P46Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P46Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM22 (FEMALE; P44Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P23Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P23Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM23 (MALE; P76Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM24 (MALE; P19Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM25 (FEMALE; P32Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Obesity (HP:0001513): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P43Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P43Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM26 (FEMALE; P45Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Obesity (HP:0001513): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P25Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM27 (FEMALE; P19Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM28 (FEMALE; P44Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM29 (FEMALE; P26Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P26Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P26Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM30 (FEMALE; P34Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.898G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P26Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P26Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P44Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P44Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM31 (FEMALE; P43Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Pancreatitis (HP:0001733): onset ; Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P26Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P26Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM32 (FEMALE; P29Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM33 (FEMALE; P21Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P30Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P30Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P38Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P38Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM34 (FEMALE; P30Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P42Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P42Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM35 (FEMALE; P59Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P36Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P36Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM36 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P55Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P55Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM37 (FEMALE; P60Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P31Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P31Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM38 (MALE; P42Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P43Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P43Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM39 (MALE; P43Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P50Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P50Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM40 (FEMALE; P54Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1357C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM41 (FEMALE; P41Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1622G>C (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P57Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P57Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM42 (FEMALE; P18Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1751G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Obesity (HP:0001513): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P25Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P36Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P36Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM43 (FEMALE; P37Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P29Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P29Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM44 (FEMALE; P37Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1045C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P20Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P20Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM45 (MALE; P26Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1045C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P20Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P20Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM46 (FEMALE; P9Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1744C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM47 (FEMALE; P4Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.29C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Generalized lipodystrophy (HP:0009064): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Pancreatitis (HP:0001733): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM48 (FEMALE; P48Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1604G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P47Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P47Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM49 (FEMALE; P70Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P79Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P79Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM50 (MALE; P77Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P77Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P77Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM51 (MALE; P46Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Overweight (HP:0025502): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM52 (MALE; P71Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Overweight (HP:0025502): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient UM53 (FEMALE; P47Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR1 (FEMALE; P69Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P28Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P28Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR2 (FEMALE; P58Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P38Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P38Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR3 (FEMALE; P50Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P42Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P42Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR4 (FEMALE; P57Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P45Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P45Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR5 (FEMALE; P55Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P40Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P40Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR6 (FEMALE; P43Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR7 (MALE; P58Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P46Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P46Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR8 (FEMALE; P32Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1445G>A (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR9 (MALE; P55Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR10 (FEMALE; P38Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Pancreatitis (HP:0001733): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P22Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P22Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR11 (MALE; P65Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Increased LDL cholesterol concentration (HP:0003141): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P40Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P40Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR12 (FEMALE; P7Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR13 (FEMALE; P32Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P22Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P22Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR14 (MALE; P11Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR15 (MALE; P50Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P42Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P42Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR16 (MALE; P47Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Obesity (HP:0001513): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P45Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P45Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR17 (FEMALE; P39Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P24Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P24Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR18 (FEMALE; P46Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P26Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P26Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR19 (FEMALE; P31Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR20 (FEMALE; P34Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P27Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P27Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR21 (FEMALE; P58Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P51Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P51Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR22 (FEMALE; P53Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P40Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P40Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR23 (FEMALE; P41Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR24 (FEMALE; P41Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR25 (FEMALE; P17Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Pancreatitis (HP:0001733): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR26 (MALE; P37Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR27 (FEMALE; P11Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Type II diabetes mellitus (HP:0005978): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR28 (FEMALE; P18Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P17Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P17Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR29 (FEMALE; P29Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Elevated hemoglobin A1c (HP:0040217): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P23Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P23Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR30 (FEMALE; P23Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P18Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P18Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR31 (MALE; P54Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Hepatic steatosis (HP:0001397): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P49Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P49Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR32 (FEMALE; P41Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hypercholesterolemia (HP:0003124): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P21Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P21Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR33 (FEMALE; P70Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P30Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P30Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR34 (MALE; P75Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hypertriglyceridemia (HP:0002155): onset ; Hepatic steatosis (HP:0001397): onset ; Decreased HDL cholesterol concentration (HP:0003233): onset ; Overweight (HP:0025502): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P45Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P45Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR35 (MALE; P57Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Elevated hemoglobin A1c (HP:0040217): onset ; Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Overweight (HP:0025502): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Hypertriglyceridemia (HP:0002155): onset ; excluded: Hypercholesterolemia (HP:0003124): onset ; excluded: Decreased HDL cholesterol concentration (HP:0003233): onset ; excluded: Increased LDL cholesterol concentration (HP:0003141): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P46Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P46Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR36 (FEMALE; P42Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; Premature coronary artery atherosclerosis (HP:0005181): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Obesity (HP:0001513): onset ; excluded: Overweight (HP:0025502): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset <br/><b>TimeElement(element=Age(iso8601duration=P25Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">TR37 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Lipodystrophy, familial partial, type 2 (OMIM:151660)</td><td style=\"text-align: left;\">NM_170707.4:c.1444C>T (heterozygous)</td><td style=\"text-align: left;\">Loss of subcutaneous adipose tissue in limbs (HP:0003635): onset ; Loss of truncal subcutaneous adipose tissue (HP:0009002): onset ; Lipodystrophy (HP:0009125): onset ; Hepatic steatosis (HP:0001397): onset ; excluded: Pancreatitis (HP:0001733): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Premature coronary artery atherosclerosis (HP:0005181): onset <br/><b>TimeElement(element=Age(iso8601duration=P28Y))</b>: Type II diabetes mellitus (HP:0005978): onset age {\n",
       "  iso8601duration: \"P28Y\"\n",
       "}\n",
       "</td></tr>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table = IndividualTable(cvalidator.get_error_free_individual_list())\n",
    "display(HTML(table.to_html()))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ps24venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
